Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
biotech
deals
gene therapy
medicare
merck
novartis
pfizer
spark therapeutics
alnylam pharmaceuticals
amicus therapeutics
biogen
biomarin pharmaceutical
cancer
What
bio
4
×
patients
4
×
roundup
drug
gene
moves
therapy
acquisitions
advantages
albert
aren’t
bar
becker
biggest
billions
bourla
brings
ceo
company
crispr
developers
dollars
drugs
eaton
expect
fda
future
gamble
healthcare
help
imminent
impact
imports
life
long
maker
maps
market
measured
medco’s
Language
unknown
unset
Current search:
bio
×
patients
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
